Article History
Received: 23 January 2022
Accepted: 15 June 2022
First Online: 4 July 2022
Declarations
:
: NV: Research support (not related to this work) for clinical trials to the institution (MGH): Pfizer, Daehwa, Radius, Merck, Novartis. Advisory Board participation (single session, not related to this work): OncoSec, AbbVie, and Gilead. CY: Research funding (not related to this work) to the institution (UCSF): NCI and Quantum Leap Healthcare Collaborative.HSR: Research support (not related to this work) for clinical trials through the University of California: Pfizer, Merck, Novartis, Lilly, Roche, Odonate, Daiichi, Seattle Genetics, Macrogenics, Sermonix, Astra Zeneca, OBI, Gilead, Ayala. Honoraria (not related to this work): Puma, Samsung, Napo.
: Institutional Review Board review and consent of patients was not required for this study as it involved analysis of publically available de-identified datasets.
: N/A.
: N/A.